Twitxy Saved

Glenn J. Hanna, M.D.

@ctdnaMD

Clinical Director / Oncology Clinical Development / Natera, Inc.
Board certified medical oncologist. Clinical researcher.
Boston, MA Joined November 2019
405 Following 1.3K Followers 424 Posts

Latest posts 5

Glenn J. Hanna, M.D. @ctdnaMD
Once patients know about ctDNA they tend to view it positively, finding it reassuring and trusting their care team to interpret results. Great to see Dr. Rettig presenting this work.
How do patients feel about #ctDNA based testing? Eleni Rettig from @DanaFarber discusses patient perceptions and trust. Overall well supported by our patients #NextGenHN @jdschoenfeld1 @Nate_Verhagen @ctdnaMD @DrUppaluri
View quoted post on X
0 replies 1 reposts 18 likes 860 views View on X
Glenn J. Hanna, M.D. @ctdnaMD
Nice to see prospective validation of pre-treatment ctDNA burden as prognostic in EWS. 💚💙🧪🩸🩺
Journal of Clinical Oncology Verified account @JCO_ASCO Sep 25
Circulating Tumor DNA Profiling Defines Risk Classification in Patients With Ewing Sarcoma: A Report from the Children’s Oncology Group and the LEOPARD Study.

Read the full article. bit.ly/4y17Ehz
View quoted post on X
1 replies 1 reposts 12 likes 1.2K views View on X
Glenn J. Hanna, M.D. @ctdnaMD
Recently published:
Safety and efficacy of a selective inhibitor of cyclin-dependent kinase 9 (KB-0742) in patients with recurrent or metastatic #adenoidcysticcarcinoma, by Glenn J. Hanna et al. doi.org/10.1158/2767-9…
@HeadNeckMD @DanaFarber @JyotiMalhotraMD #CDK9 #OpenAccess
View quoted post on X
0 replies 1 reposts 1 likes 1.4K views View on X